MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
0.2200
0.0000
0.00%
After Hours: 0.2203 +0.0003 +0.14% 19:52 09/04 EDT
OPEN
0.2200
PREV CLOSE
0.2200
HIGH
0.2378
LOW
0.2174
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
1.550
52 WEEK LOW
0.1952
MARKET CAP
12.31M
P/E (TTM)
-0.3403
1D
5D
1M
3M
1Y
5Y
1D
PDS Biotechnology Amends Promissory Note, Tightens Financing Terms
TipRanks · 3d ago
PDS Biotechnology’s Phase 3 Head and Neck Cancer Trial Termination: What It Means for Investors
TipRanks · 5d ago
Weekly Report: what happened at PDSB last week (0824-0828)?
Weekly Report · 08/31 09:06
PDS Biotechnology Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones · 08/26 11:38
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target
Benzinga · 08/26 11:28
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 08/26 10:20
PDS Biotechnology Restructures Workforce and Leadership Team
TipRanks · 08/25 20:29
PDS Biotechnology Intends To Cut Workforce By 36%; Removes Stephan Toutain As COO, Effective Aug. 21
Benzinga · 08/25 20:11
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.